“…THE astonishing promise of griseofulvin as an antimycotic agent has caused a considerable number of dermatologists to burst into print with enthusiastic preliminary reports on its apparent value in the treatment of the superficial mycoses (Williams eY al, 1958: Blank and Roth, 1959Latapi. 1959;Pardo-Costello et al, 1959;Riehl, lU59a and 6 ;Mitchell, 1959;Kirk andAjello, 1959 andCochrane andTullett, 1959). Most of these reports, although interesting, have an unfortunate factor in common-the time spent in following up the patients seems to have been reduced to an unscientitically low period, and indeed some papers actually report cases which were still being treated at the time of writing.…”